Inventor · disambiguated record
Tzyy-Choou Wu
Also filed as: WU TZYY-CHOOU
15 granted patents·16 pending applications·154 citations·filing 2000–2020
92Inventor score
Top patents by PatentIndex Score
31 records- 0193US7557200B2Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentationUNIV JOHNS HOPKINS·Filed 2002·Granted Jul 7, 2009·55 cites·36 claims
- 0293US6734173B1HSP DNA vaccinesUNIV JOHNS HOPKINS·Filed 2000·Granted May 11, 2004·42 cites·34 claims
- 0390US10799579B2Methods for enhancing antigen-specific immune responsesUNIV JOHNS HOPKINS·Filed 2016·Granted Oct 13, 2020·4 cites·4 claims
- 0486US9085638B2DNA vaccine enhancement with MHC class II activatorsWU TZYY-CHOOU·Filed 2008·Granted Jul 21, 2015·4 cites·9 claims
- 0586US7342002B2Molecular vaccine linking an endoplasmic chaperone polypeptide to an antigenUNIV JOHNS HOPKINS·Filed 2001·Granted Mar 11, 2008·16 cites·41 claims
- 0685US11766478B2Methods for enhancing antigen-specific immune responsesUNIV JOHNS HOPKINS·Filed 2020·Granted Sep 26, 2023·1 cites·9 claims
- 0785US8128922B2Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigenWU TZYY-CHOOU·Filed 2002·Granted Mar 6, 2012·18 cites·36 claims
- 0884US8007781B2Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigenUNIV JOHNS HOPKINS·Filed 2008·Granted Aug 30, 2011·4 cites·7 claims
- 0982US9758551B2Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigenWU TZYY-CHOOU·Filed 2012·Granted Sep 12, 2017·3 cites·5 claims
- 1081US9011866B2RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccinesWU TZYY-CHOOU·Filed 2007·Granted Apr 21, 2015·4 cites·31 claims
- 1179US10350282B2Mesothelin vaccines and model systemsUNIV JOHNS HOPKINS·Filed 2016·Granted Jul 16, 2019·1 cites·4 claims
- 1272US9701725B2Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock proteinWU TZYY-CHOOU·Filed 2004·Granted Jul 11, 2017·2 cites·16 claims
- 1368US11285197B2Mesothelin vaccines and model systemsUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 29, 2022·0 cites·9 claims
- 1468US2020354412A1Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock proteinUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 1560US2018141983A1Anti-Cancer DNA Vaccine Employing Plasmids Encoding Signal Sequence, Mutant Oncoprotein Antigen, and Heat Shock ProteinUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 1660US2009285861A1Tumor cell-based cancer immunotherapeutic compositions and methodsWU TZYY-CHOOU·Filed 2009·Application pending·0 cites
- 1759US2008260765A1HPV DNA Vaccines and Methods of Use ThereofUNIV JOHNS HOPKINS·Filed 2008·Application pending·0 cites
- 1857US2008286292A1Molecular vaccine linking intercellular spreading protein to an antigenWU TZYY-CHOOU·Filed 2007·Application pending·0 cites
- 1957US2005175625A1Mesothelin vaccines and model systemsUNIV JOHNS HOPKINS·Filed 2003·Application pending·0 cites
- 2055US2013203961A1Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an AntigenWU TZYY-CHOOU·Filed 2012·Application pending·0 cites
- 2154US2016317641A1Methods of Treatment of HPV Related DiseasesUNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 2254US2015182621A1Compositions and methods for enhancing antigen-specific immune responsesUNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 2353US2013122048A1Tumor Cell-Based Cancer Immunotherapeutic Compositions and MethodsWU TZYY-CHOOU·Filed 2012·Application pending·0 cites
- 2450US2010330105A1Anticancer Combination TherapiesUNIV JOHNS HOPKINS·Filed 2007·Application pending·0 cites
- 2549US11987606B2Compositions and methods for enhancing an immune responseUNIV JOHNS HOPKINS·Filed 2016·Granted May 21, 2024·0 cites·13 claims
- 2649US2007026076A1Molecular vaccines employing nucleic acid encoding anti-apoptotic proteinsWU TZYY-CHOOU·Filed 2004·Application pending·0 cites
- 2748US12434236B2Methods and materials for treating cancerUNIV JOHNS HOPKINS·Filed 2020·Granted Oct 7, 2025·0 cites·12 claims
- 2848US2008102084A1Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and CalreticulinWU TZYY-CHOOU·Filed 2007·Application pending·0 cites
- 2947US2023203104A1Compositions comprising annexin v and hpv tumor antigen fusion polypeptides and methods for making and useUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 3042US2012225090A1Methods for enhancing antigen-specific immune responsesWU TZYY-CHOOU·Filed 2010·Application pending·0 cites
- 3142US2012244173A1Compositions and Methods for Enhancing Antigen-Specific Immune ResponsesWU TZYY-CHOOU·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →